KITE PHARMA INC's ticker is KITE and the CUSIP is 49803L109.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2017 | $44,612,000 | -64.8% | 248,104 | -79.7% | 1.81% | -69.4% |
| Q2 2017 | $126,882,000 | +12.7% | 1,223,899 | -14.6% | 5.91% | +3.6% |
| Q1 2017 | $112,547,000 | +99.4% | 1,433,899 | +13.9% | 5.71% | +97.0% |
| Q4 2016 | $56,449,000 | +0.2% | 1,258,899 | +24.8% | 2.90% | -6.6% |
| Q3 2016 | $56,357,000 | +64.6% | 1,008,899 | +47.3% | 3.10% | +60.2% |
| Q2 2016 | $34,245,000 | +50.7% | 684,899 | +38.4% | 1.94% | +42.3% |
| Q1 2016 | $22,725,000 | -7.8% | 494,988 | +23.8% | 1.36% | -13.4% |
| Q4 2015 | $24,648,000 | +8.0% | 399,988 | -2.4% | 1.57% | -7.8% |
| Q3 2015 | $22,828,000 | -24.8% | 410,002 | -17.7% | 1.70% | -26.2% |
| Q2 2015 | $30,366,000 | +96.0% | 498,060 | +85.5% | 2.31% | +84.3% |
| Q1 2015 | $15,489,000 | – | 268,530 | – | 1.25% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Wildcat Capital Management, LLC | 2,410,034 | $433,348,000 | 77.71% |
| COWEN INC. | 4,200,600 | $755,310,000 | 26.72% |
| Tyrus Capital S.A.M. | 1,314,812 | $236,416,000 | 18.49% |
| OMNI PARTNERS LLP | 661,711 | $118,982,000 | 15.19% |
| FNY Partners Fund LP | 379,510 | $68,239,000 | 11.61% |
| EQUITEC PROPRIETARY MARKETS, LLC | 240,100 | $43,172,000 | 10.15% |
| EQUITEC PROPRIETARY MARKETS, LLC | 227,500 | $40,907,000 | 9.62% |
| GARDNER LEWIS ASSET MANAGEMENT L P | 773,817 | $139,140,000 | 8.89% |
| Quad Capital Management Advisors LLC | 192,537 | $34,620,000 | 7.10% |
| Avoro Capital Advisors LLC | 496,983 | $89,363,000 | 6.93% |